Literature DB >> 33446314

Cardiovascular Complications of Opioid Use: JACC State-of-the-Art Review.

Mori J Krantz1, Robert B Palmer2, Mark C P Haigney3.   

Abstract

Opioids are the most potent of all analgesics. Although traditionally used solely for acute self-limited conditions and palliation of severe cancer-associated pain, a movement to promote subjective pain (scale, 0 to 10) to the status of a "fifth vital sign" bolstered widespread prescribing for chronic, noncancer pain. This, coupled with rising misuse, initiated a surge in unintentional deaths, increased drug-associated acute coronary syndrome, and endocarditis. In response, the American College of Cardiology issued a call to action for cardiovascular care teams. Opioid toxicity is primarily mediated via potent μ-receptor agonism resulting in ventilatory depression. However, both overdose and opioid withdrawal can trigger major adverse cardiovascular events resulting from hemodynamic, vascular, and proarrhythmic/electrophysiological consequences. Although natural opioid analogues are devoid of repolarization effects, synthetic agents may be proarrhythmic. This perspective explores cardiovascular consequences of opioids, the contributions of off-target electrophysiologic properties to mortality, and provides practical safety recommendations.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  QT-prolongation; arrhythmia; dextromethorphan; endocarditis; hERG channel; levacetylmethadol; loperamide; methadone; mortality; opioid mortality; opioid overdose; opioid withdrawal; opioids; propoxyphene; torsade de pointes

Mesh:

Substances:

Year:  2021        PMID: 33446314     DOI: 10.1016/j.jacc.2020.11.002

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine.

Authors:  Cindy Xinxin Du; Julia Shi; Jeanette M Tetrault; Lynn M Madden; Declan T Barry
Journal:  Fam Pract       Date:  2022-03-24       Impact factor: 2.267

Review 2.  Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article.

Authors:  Farshid Etaee; Morgan Tobin; Suchith Vuppala; Alireza Komaki; Brian P Delisle; Luigi Di Biase; John N Catanzaro; Andrea Natale; Claude S Elayi
Journal:  J Interv Card Electrophysiol       Date:  2021-10-21       Impact factor: 1.900

3.  Association of Medication-Assisted Therapy with New Onset of Cardiac Arrhythmia in Patients Diagnosed with Opioid Use Disorders.

Authors:  Mukaila A Raji; Shivani Priyadarshni; Xiaoying Yu; Biai Digbeu; Yong-Fang Kuo
Journal:  Am J Med       Date:  2022-02-06       Impact factor: 5.928

4.  Long-term opioid use and mortality in patients with chronic non-cancer pain: Ten-year follow-up study in South Korea from 2010 through 2019.

Authors:  In-Ae Song; Hey-Ran Choi; Tak Kyu Oh
Journal:  EClinicalMedicine       Date:  2022-07-18

5.  Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40 000-cases across two countries.

Authors:  Talip E Eroglu; Carlo A Barcella; Marieke T Blom; Patrick C Souverein; Grimur H Mohr; Christian Torp-Pedersen; Fredrik Folke; Mads Wissenberg; Anthonius de Boer; Gunnar H Gislason; Hanno L Tan
Journal:  Br J Clin Pharmacol       Date:  2021-12-23       Impact factor: 3.716

6.  A Peculiar Case of Fentanyl-Induced Cardiomyopathy.

Authors:  Faraz Badar; Aqsa Ashraf; Md R Bhuiyan; Tia Bimal; Asma Iftikhar
Journal:  Cureus       Date:  2022-08-05

7.  Methadone Blockade of Cardiac Inward Rectifier K+ Current Augments Membrane Instability and Amplifies U Waves on Surface ECGs: A Translational Study.

Authors:  Michael G Klein; Mori J Krantz; Naheed Fatima; Ashlie Watters; Dayan Colon-Sanchez; Robert M Geiger; Robert E Goldstein; Soroosh Solhjoo; Philip S Mehler; Thomas P Flagg; Mark C Haigney
Journal:  J Am Heart Assoc       Date:  2022-06-06       Impact factor: 6.106

Review 8.  Non-Opioid Peptides Targeting Opioid Effects.

Authors:  Katarzyna Kaczyńska; Piotr Wojciechowski
Journal:  Int J Mol Sci       Date:  2021-12-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.